Risk for borderline ovarian tumours after exposure to fertility drugs: Results of a population-based cohort study

Human Reproduction

Volumn 30, Issue 1, 2015, Pages 222-231

  Bjornholt, Sarah Marie ^a   Kjaer, Susanne Kruger ^a,b   Nielsen, Thor Schutt Svane ^a   Jensen, Allan ^a  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

borderline ovarian tumours; Denmark; fertility drugs; infertility; population based cohort study

Indexed keywords

CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; GONADORELIN; GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; PROGESTERONE; FERTILITY PROMOTING AGENT;

ADULT; ARTICLE; BORDERLINE OVARIAN TUMOR; CANCER RISK; COHORT ANALYSIS; DEATH; DISEASE ASSOCIATION; DRUG EXPOSURE; FEMALE; FEMALE INFERTILITY; FOLLOW UP; HEALTH CARE FACILITY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; OVARY TUMOR; RETROSPECTIVE STUDY; OVARIAN NEOPLASMS; PATHOLOGY; RISK FACTOR;

FEMALE; FERTILITY AGENTS, FEMALE; HUMANS; OVARIAN NEOPLASMS; PROGESTERONE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84922434144     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deu297     Document Type: Article

References (39)

1. Asante A, Leonard PH, Weaver AL, Goode EL, Jensen JR, Stewart EA, Coddington CC. Fertility drug use and the risk of ovarian tumors in infertile women: a case-control study. Fertil Steril 2013; 7:2031-2036.
2. Baldur-Felskov B, Kjaer SK, Albieri V, Steding-Jessen M, Kjaer T, Johansen C, Dalton SO, Jensen A. Psychiatric disorders in women with fertility problems: results from a large Danish register-based cohort study. Hum Reprod 2013;3:683-690.
3. Barlow WE. Robust variance estimation for the case-cohort design. Biometrics 1994;4:1064-1072.
4. Barlow WE, Ichikawa L, Rosner D, Izumi S. Analysis of case-cohort designs. J Clin Epidemiol 1999;12:1165-1172.
5. Beral V, Bull D, Green J, Reeves G. Ovarian cancer and hormone replacement therapy in the Million Women Study. Lancet 2007;9574: 1703-1710.
6. Bjerregaard B, Larsen OB. The Danish Pathology Register. Scand J Public Health 2011;39:72-74.
7. Brinton LA, Lamb EJ, Moghissi KS, Scoccia B, Althuis MD, Mabie JE, Westhoff CL. Ovarian cancer risk after the use of ovulation-stimulating drugs. Obstet Gynecol 2004;6:1194-1203.
8. Cusido M, Fabregas R, Pere BS, Escayola C, Barri PN. Ovulation induction treatment and risk of borderline ovarian tumors. Gynecol Endocrinol 2007;7:373-376.
9. Diergaarde B, Kurta ML. Use of fertility drugs and risk of ovarian cancer. Curr Opin Obstet Gynecol 2014;3:125-129.
10. Ferraretti AP, Goossens V, Kupka M, Bhattacharya S, de MJ, Castilla JA, Erb K, Korsak V, Nyboe Andersen A, ; European IVF-Monitoring (EIM) Consortium for the European Society of Human Reproduction and Embryology (ESHRE). Assisted reproductive technology in Europe, 2009: results generated from European registers by ESHRE. Hum Reprod 2013;9:2318-2331.
11. Franks LM, Teich NM. Introduction to the Cellular and Molecular Biology of Cancer, 3rd edn. New York: Oxford University Press, 2003.
12. Gjerstoff ML. The Danish Cancer Registry. Scand J Public Health 2011; 39:42-45.
13. Hannibal CG, Huusom LD, Kjaerbye-Thygesen A, Tabor A, Kjaer SK. Trends in incidence of borderline ovarian tumors in Denmark 1978-2006. Acta Obstet Gynecol Scand 2011;4:305-312.
14. Hannibal CG, Vang R, Junge J, Frederiksen K, Kjaerbye-Thygesen A, Andersen KK, Tabor A, Kurman RJ, Kjaer SK. A nationwide study of serous borderline ovarian tumors in Denmark 1978-2002: Centralized pathology review and overall survival compared with the general population. Gynecol Oncol 2014;2:267-273.
15. Harris R, Whittemore AS, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. III. Epithelial tumors of low malignant potential in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol 1992;10:1204-1211.
16. Jensen A, Sharif H, Frederiksen K, Kjaer SK. Use of fertility drugs and risk of ovarian cancer: Danish Population Based Cohort Study. BMJ 2009; 338:b249.
17. Juul S, KarmausW, Olsen J. Regional differences in waiting time to pregnancy: pregnancy-based surveys from Denmark, France, Germany, Italy and Sweden. The European Infertility and Subfecundity Study Group. Hum Reprod 1999;5:1250-1254.
18. Kjaerbye-Thygesen A, Huusom LD, Frederiksen K, Kjaer SK. Primary ovarian cancer. A comparison of registrations in the Danish Cancer Registry and the Pathology Data Bank. Ugeskr Laeger 2007;1:50-54.
19. Kurta ML, Moysich KB, Weissfeld JL, Youk AO, Bunker C, Edwards RP, Modugno F, Ness RB, Diergaarde B. Use of fertility drugs and risk of ovarian cancer: results from a US-based case-control study. Cancer Epidemiol Biomarkers Prev 2012;8:1282-1292.
20. Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health 2011;7:30-33.
21. Morch LS, Lokkegaard E, Andreasen AH, Kjaer SK, Lidegaard O. Hormone therapy and ovarian borderline tumors: a national cohort study. Cancer Causes Control 2012;1:113-120.
22. Mosgaard BJ, Lidegaard O, Kjaer SK, Schou G, Andersen AN. Ovarian stimulation and borderline ovarian tumors: a case-control study. Fertil Steril 1998;6:1049-1055.
23. National Toxicology Program. 12th Report on Carcinogens (Rep Carcinog 2011). National Institute of Environmental Health Standards, Research Triangle Park, North Carolina.
24. NessRB, CramerDW, GoodmanMT, KjaerSK, Mallin K, MosgaardBJ, PurdieDM, Risch HA, Vergona R, Wu AH. Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies. Am J Epidemiol 2002;3:217-224.
25. Parazzini F, Negri E, La Vecchia C, Moroni S, Polatti A, Chiaffarino F, Surace M, Ricci E. Treatment for fertility and risk of ovarian tumors of borderline malignancy. Gynecol Oncol 1998;3:226-228.
26. Prentice RL. A case-cohort design for epidemiological cohort studies and disease prevention trials. Biometrika 1986;73:1-11.
27. Rizzuto I, Behrens RF, Smith LA. Risk of ovarian cancer inwomentreated with ovarian stimulating drugs for infertility. Cochrane Database Syst Rev 2013; 8:CD008215.
28. Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. Ovarian tumors in a cohort of infertile women. N Engl J Med 1994;12:771-776.
29. Rossing MA, Tang MT, Flagg EW, Weiss LK, Wicklund KG. A case-control study of ovarian cancer in relation to infertility and the use of ovulationinducing drugs. Am J Epidemiol 2004;11:1070-1078.
30. Sallum LF, Sarian LO, Lucci De Angelo AL, Vassallo J, Soares FA, Pinto GA, Ferreira PA, Derchain S. Survival of women with ovarian carcinomas and borderline tumors is not affected by estrogen and progesterone receptor status. J Gynecol Oncol 2013;2:167-176.
31. Sanner K, Conner P, Bergfeldt K, Dickman P, Sundfeldt K, Bergh T, Hagenfeldt K, Janson PO, Nilsson S, Persson I. Ovarian epithelial neoplasia after hormonal infertility treatment: long-term follow-up of a historical cohort in Sweden. Fertil Steril 2008;4:1152-1158.
32. Scully RE. World Health Organization classification and nomenclature of ovarian cancer. Natl Cancer Inst Monogr 1975;42:5-7.
33. Shushan A, Paltiel O, Iscovich J, Elchalal U, Peretz T, Schenker JG. Human menopausal gonadotropin and the risk of epithelial ovarian cancer. Fertil Steril 1996;1:13-18.
34. Skirnisdottir I, GarmoH, Wilander E, Holmberg L. Borderline ovarian tumors in Sweden 1960-2005: trends in incidence and age at diagnosis compared to ovarian cancer. Int J Cancer 2008;8:1897-1901.
35. Stewart LM, Holman CD, Finn JC, Preen DB, Hart R. In vitro fertilization is associated with an increased risk of borderline ovarian tumours. Gynecol Oncol 2013;2:372-376.
36. Tavassoli FA, Devilee P (eds). World Health Organization Classification of Tumours. Pathology and Genetics, Tumours of the Breast and Female Genital Organs. Lyon: IARC Press, 2003.
37. van Leeuwen FE, Klip H, Mooij TM, van de Swaluw AM, Lambalk CB, Kortman M, Laven JS, Jansen CA, Helmerhorst FM, Cohlen BJ et al. Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort. Hum Reprod 2011; 12:3456-3465.
38. Whittemore AS, Harris R, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol 1992;10:1184-1203.
39. Yli-Kuha AN, Gissler M, Klemetti R, Luoto R, Hemminki E. Cancer morbidity in a cohort of 9175 Finnish womentreated for infertility.HumReprod 2012; 4:1149-1155.